New drug to inhibit bone loss called Skelid (SKEL-id, tiludronate)

Sanofi is launching a new drug to inhibit bone loss called Skelid (SKEL-id, tiludronate). It...

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote